A052101
OPEN TO ACCRUAL
Ph 3 Study of Continuous v Intermittent Zanubrutinib Maintenance Therapy in Older Patients with MCL
ACCL1931
OPEN TO ACCRUAL
Ph3 Levocarnitine Prophylaxis for AYA in ALL Therapy
EA4232
OPEN TO ACCRUAL
R Ph3 study to Eval Benefits of ASCT in pts w/ PTCL that achieved a CR1 Following Induction Therapy
S2114
OPEN TO ACCRUAL
Ph II Trial of Consolidation Tx Following CD19 CAR T Tx for Relapse/Refractory DLBCL or Gr IIIB FL
UW19086
OPEN TO ACCRUAL
LTFU Protocol for Subjects Treated with Gene-Modified T Cells
UW20062
OPEN TO ACCRUAL
Metabolic Profiling of Leukemic Cells through Isotope Tracing in Patients with CLL
UW24107
OPEN TO ACCRUAL
Ph3 Study of Soquelitinib vs. Physician's Choice in Pts w/ R/R PTCL-NOS, FHTCL or sALCL